NIH-funded research NIH-funded research

Investigating how Epstein-Barr virus proteins affect gene regulation

Official title: Epstein-Barr Virus nuclear antigen leader protein in transcription regulation

Funded at University of Minnesota · NIH-11106009 · Data updated 2026-11-12

This study is looking at how a protein from the Epstein-Barr virus affects gene activity in cells, especially in people with HIV, to better understand how it might lead to certain diseases and cancers.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startJune 1, 2023
Project endMay 31, 2026
Funding year2025
Award (this year)$247,473
NIH project number5R00DE030215-05
Project IDNIH-11106009 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals infected with the Epstein-Barr virus, particularly those with HIV or related B cell malignancies.

Less likely to help

Patients who do not have EBV infection or related conditions may not benefit from this research.

What this research studies

This research focuses on understanding the role of the Epstein-Barr virus (EBV) nuclear antigen leader protein in regulating gene expression. By using EBV-transformed lymphoblastoid cell lines, researchers will explore how this protein interacts with host DNA to influence the development of diseases associated with EBV, particularly in individuals with HIV. The study employs advanced techniques such as CRISPR to identify the mechanisms by which this viral protein contributes to the transformation of B lymphocytes and the progression of related cancers.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating EBV-related diseases and cancers.

How similar studies have gone: Previous research has shown promising results in understanding viral mechanisms in cancer, suggesting potential for success in this area.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Wang, Chong — University of Minnesota
  • Study coordinator: Wang, Chong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.